Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 19, Issue 2, 2009, Pages 110-114

  Dall'Asta, C ^a,b   Vedani, P ^c   Manunta, P ^c   Pizzocri, P ^c   Marchi, M ^c   Paganelli, M ^c   Folli, F ^d   Pontiroli, A E ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Ospedale San Paolo   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Aldosterone; Arterial hypertension; Bariatric surgery; Obesity; Renin; Weight loss

Indexed keywords

ALDOSTERONE; INSULIN; LIPID; POTASSIUM; RENIN; SODIUM;

ADULT; ARTICLE; BARIATRIC SURGERY; BLOOD; BLOOD PRESSURE; DOWN REGULATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LAPAROSCOPY; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MORBID OBESITY; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TIME; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; ALDOSTERONE; BARIATRIC SURGERY; BLOOD GLUCOSE; BLOOD PRESSURE; DOWN-REGULATION; FEMALE; HUMANS; HYPERTENSION; INSULIN; LAPAROSCOPY; LIPIDS; MALE; MIDDLE AGED; OBESITY, MORBID; POTASSIUM; RENIN; RENIN-ANGIOTENSIN SYSTEM; SODIUM; TIME FACTORS; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 60349087302     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2008.06.001     Document Type: Article

References (36)

1. Calle E.E., Thun M.J., Petrelli J.M., Rodriguez C., and Heath C.W.J. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341 (1999) 1097-1105
2. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walzer E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
3. Torgerson J.S., Hauptman J., Boldrin M.N., and Sjostrom L. Xenical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for prevention of type 2 diabetes in obese patients. Diabetes Care 27 (2004) 155-161
4. Sheen A.J., Finer M., Hollander P., Jensen M.D., Van Gaal L.F., and RIO-Diabetes Study Group. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomized controlled study. Lancet 368 (2006) 1660-1672
5. Pontiroli A.E., Pizzocri P., Librenti M.C., Vedani P., Marchi M., Cucchi E., et al. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three year study. J Clin Endocrinol Metab 87 (2002) 3555-3561
6. Pontiroli A.E., Pizzocri P., and Saibene A. Left ventricular hypertrophy and QT interval in obesity and in hypertension: effects of weight loss and of normalisation of blood pressure. Int J Obes 281 (2004) 118-1123
7. Sjostrom L., Lindroos A., Peltonen M., Torgerson J., Bouchard C., Carlsson B., et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351 (2004) 2684-2693
8. Buchwald H., Avidor Y., Braunwald E., Jensen M.D., Pories W., Fahrbach K., et al. Bariatric Surgery. A systematic review and meta-analysis. JAMA 292 (2004) 1724-1737
9. Pontiroli A.E., Folli F., Paganelli M., Micheletto G., Pizzocri P., Vedani P., et al. Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity - a 4 year case-controlled study. Diabetes Care 28 (2005) 2703-2709
10. Wolk R., Shamsuzzaman A.S.M., and Somers V.K. Obesity, sleep apnea and hypertension. Hypertension 42 (2003) 1067-1074
11. Pontiroli A.E., Pizzocri P., Paroni R., and Folli F. Sympathetic overactivity, endothelial dysfunction, inflammation, and metabolic abnormalities cluster in grade III (World Health Organization) obesity. Diabetes Care 29 (2006) 2735-2738
12. Hiramatsu K., Yamada T., Ichikawa K., Izumiyama T., and Nagata H. Changes in endocrine activities relative to obesity in patients with essential hypertension. J Am Geriatr Soc 29 (1981) 25-30
13. Rocchini A.P., Katch V.L., Grekin R., Moorehead C., and Anderson J. Role for aldosterone in blood pressure regulation of obese adolescents. Am J Cardiol 57 (1986) 613-618
14. Goodfriend T.L., Kelley D.E., Goodpaster B.H., and Winters S.J. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res 7 (1999) 355-362
15. Harp J.B., Henry S.A., and DiGirolamo M. Dietary weight loss decreases serum angiotensin-converting enzyme activity in obese adults. Obes Res 10 (2002) 985-990
16. Marks P., Wilson B., and Delassalle A. Aldosterone studies in obese patients with hypertension. Am J Med Sci 289 (1985) 224-228
17. Tuck M.L., Sowers J., Dornfeld L., Kledzik G., and Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 304 (1981) 930-933
18. Maxwell M.H., Heber D., Waks A.U., and Tuck M.L. Role of insulin and norepinephrine in the hypertension of obesity. Am J Hypertens 7 (1994) 402-408
19. Reisin E., Frohlich E.D., Messerli F.H., Dreslinski G.R., Dunn F.G., Jones M.M., et al. Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med 98 (1983) 315-319
20. The Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 157 (1997) 2413-2446
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
22. Giacchetti G., Ronconi V., Lucarelli G., Boscaro M., and Mantero F. Analysis of screening and confirmatory test in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens 24 (2006) 737-745
23. Cottam R.D., Atkinsons J., Anderson A., Grace B., and Fisher B. A case-controlled matched-pair cohort study of laparoscopic roux-en-Y gastric bypass and Lap-Band patients in a single US center with three-year follow-up. Obes Surg 16 (2006) 534-540
24. Licata G., Scaglione R., Ganguzza A., Corrao S., Donatelli M., Parrinello G., et al. Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects. Am J Hypertens 7 (1994) 314-320
25. Andronico G., Cottone S., Mangano M.T., Ferraro-Mortellaro R., Baiardi G., Grassi N., et al. Insulin, renin-aldosterone system and blood pressure in obese people. Int J Obes 25 (2001) 239-242
26. Mancia G., Dell'oro R., Quarti-Trevano F., Scopelliti F., and Grassi G. Angiotensin-sympathetic system interactions and metabolic disease. J Hypertens 24 (2006) S551-S556
27. Engeli S., Böhnke J., and Gozrelniak K. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45 (2005) 356-362
28. Engeli S., and Sharma A.M. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med 79 (2001) 21-29
29. Ehrart-Bornstein M., Lamouneir-Zapter V., Schraven A., Lagenbach J., Willenberg H.S., Barthel A., et al. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A 100 (2004) 14211-14216
30. Gorzelniak K., Engeli S., and Janke J. Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens 20 (2002) 965-973
31. Jones B.H., Stanridge M.K., and Moustaid N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 138 (1999) 1512-1519
32. Hall J.E., Hildebrandt D.A., and Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 14 (2001) 103S-115S
33. Andersson B., Elam M., and Allin B.G. Effect of energy-restricted diet on sympathetic muscle nerve activity in obese women. Hypertension 18 (1991) 783-789
34. Grassi G., Serravalle G., and Colombo M. Body weight reduction, sympathetic nerve traffic, and arterial baroflex in obese normotensive humans. Circulation 97 (1998) 2037-2042
35. Kaplan N.M. Renin profiles. JAMA 238 (1997) 611-613
36. Cottam D.R., Mattar S.G., and Barinas-Mitchell E. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 14 (2004) 589-600